John Boris John Boris has joined Roth Capital Partners’ healthcare investment banking team as a managing director. Prior to joining Roth, Mr. Boris was the managing partner of JTB Capital Management, where he invested...

Jonathan Talamo Closely-held Ripple Therapeutics named Jonathan Talamo, M.D., an internationally known ophthalmologist, innovator and consultant to the industry with more than 25 years of experience in healthcare, to...

X-ray manufacturer, KA Imaging, appointed Dr. Philip Templeton, M.D., to the newly created position of chief medical officer (CMO). A board certified radiologist, Dr. Templeton brings over 38 years of academic and...

Nurx, a telehealth platform providing convenient and affordable care for female health needs, appointed Dr. Jennifer Peña, M.D., as chief medical officer to help Nurx build on a record year of growth and begin treating...

Jim Lilly Jim Lilly joined England & Co., a middle-market investment bank, as a managing director in its New York office. Mr. Lilly brings more than 30 years of experience as a strategic advisor to a wide variety of...

Justin Zelin BTIG has expanded its healthcare research coverage, adding Justin Zelin to its research and strategy division as a director. His biotech research coverage will include cell therapy, targeted oncology...

Joseph Walewicz Closely-held Fibrocor Therapeutics appointed Joseph Walewicz, a biotech veteran with more than 25 years of experience in finance, capital markets and business development, as CFO. Prior to joining...